Denka Co. Ltd. (TYO:4061) announced on July 20 that it has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), looking here to get domestic regulatory approval for an in vitro diagnostic agent to be used in simple COVID-19 test kits. To help with developing the kit, Denka has pursued collaborative research with the National Institute of Infectious...
[lwa template="modal" register="0"]Subscribe
Denka Co. Ltd. (TYO:4061) announced on June 10 that it has been offered subsidies for an in-house R&D effort focused on infection testing. The company has been working here to develop and test new multiplexed diagnostics technology that targets COVID-19 alongside a range of other infections. The subsidy offer came in on May 28 from the Japan Agency for Medical...
[lwa template="modal" register="0"]Subscribe
Signup today for free.
You will receive a weekly or daily roundup on what has been published and will be up to date on special offers.
Please make sure to select your preferred sending frequency!
Note: We save your entered data to send the newsletter. You can always easily unsubscribe. More information on data handling: Privacy Policy.
Close window
